2003 to 2014 Saw Rise in Diabetic Ketoacidosis Admissions

Share this content:
2003 to 2014 Saw Rise in Diabetic Ketoacidosis Admissions
2003 to 2014 Saw Rise in Diabetic Ketoacidosis Admissions

TUESDAY, May 22, 2018 (HealthDay News) -- The incidence of hospitalization for diabetic ketoacidosis (DKA) and associated costs increased from 2003 to 2014, according to a study published online May 17 in Diabetes Care.

Dimpi Desai, M.D., from the Albert Einstein College of Medicine in Bronx, N.Y., and colleagues examined the incidence and costs of hospital admissions associated with DKA. Data were obtained from the National Inpatient Sample Database for all hospitalizations in which DKA was the principal discharge diagnosis during 2003 to 2014.

During the study period there were 1,760,101 primary admissions for DKA. The researchers found that in-hospital mortality was 0.4 percent for the cohort. There was a significant increase in the total number of hospital discharges with the principal diagnosis of DKA from 2003 to 2014, from 118,808 to 188,965. From 2003 to 2014 there was a significant decrease in the length of stay, from an average of 3.64 to 3.24 days. During the study period, the mean hospital charges increased significantly, from $18,987 to $26,566 per admission. There was an increase in the resulting aggregate charges for diabetes with ketoacidosis from $2.2 (after adjustment for inflation) to $5.1 billion from 2003 to 2014. Mortality decreased significantly during the study period, from 0.51 to 0.3 percent.

"Despite decreases in the length of stay, the costs of hospitalizations have increased significantly, indicating opportunities for value-based care intervention in this vulnerable population," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »